Diabetes Type 2. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: Intervention group:All Patients Selected from the Intervention Group Should be Treated with Oral L-Arginine Supplement Alone or dissolved in a Beverage or Liquid Food at a rate of 3 Gr
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Male Gender Erectile Dysfunction (ED) for at Least 3 Months Having Type 2 Diabetes for at Least a Year Total Testosterone Levels Less than 8 nanomol /Liter or Serum Testosterone in the Range of 8 to 11 nanomol /Liter and Free Testosterone Levels Less than 220 picomoles /Liter Age 40 to 60 Years HBA1C Between 5.5 and 7 (Low and Moderate Risk Diabetes) Do not Take Exogenous Anabolic Steroids
Exclusion criteria
Exclusion criteria: Patients with Erectile Dysfunction (ED) of known Psychological Origin Patients with Prostate Cancer or Benign Prostatic Hyperplasia Patients with a History of Sleep Apnea Patients with Spinal Cord Injury Patients with known and treated Cardiopulmonary Injury Patients with Hyperthyroidism or Hypothyroidism Patients with known Liver Failure Patients with known Renal Failure Patients with a History of Seizures Patients with known Microvascular Complications of Diabetes (Retinopathy, Neuropathy, Nephropathy Taking Anti-Libido Drugs Taking Antipsychotic or Mood Stabilizing or Antidepressant Medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of Individuals with the International Index of Erectile Function-5 Questionnaire Score of Less than 21. Timepoint: Filling in the Questionnaire at the Beginning of the Study and 8 Weeks after Taking L-Arginine Supplement or Placebo. Method of measurement: The International Index of Erectile Function-5.;Free and Total Testosterone Serum Levels. Timepoint: Measurement of Free and Total Testosterone Serum Levels at the Beginning of the Study and 8 Weeks after Taking L-Arginine Supplement or Placebo. Method of measurement: Laboratory Kit by ELISA Method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting Blood Suger. Timepoint: Measurement of Fasting Blood Sugar Levels at the Beginning of the Study and 8 Weeks after Taking L-Arginine Supplement or Placebo. Method of measurement: Laboratory Kit by ELISA Method.;Hemoglobin A1C. Timepoint: Measurement of Hemoglobin A1C Levels at the Beginning of the Study and 8 Weeks after Taking L-Arginine Supplement or Placebo. Method of measurement: Laboratory Kit by ELISA Method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahman Sadehgi
Arak University of Medical Sciences
Outcome results
None listed